112 related articles for article (PubMed ID: 10835109)
1. Design and synthesis of germline-based hemi-humanized single-chain Fv against the CD18 surface antigen.
Caldas C; Coelho VP; Rigden DJ; Neschich G; Moro AM; Brígido MM
Protein Eng; 2000 May; 13(5):353-60. PubMed ID: 10835109
[TBL] [Abstract][Full Text] [Related]
2. Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.
Caldas C; Coelho V; Kalil J; Moro AM; Maranhão AQ; Brígido MM
Mol Immunol; 2003 May; 39(15):941-52. PubMed ID: 12695120
[TBL] [Abstract][Full Text] [Related]
3. Humanization of 60.3, an anti-CD18 antibody; importance of the L2 loop.
Hsiao KC; Bajorath J; Harris LJ
Protein Eng; 1994 Jun; 7(6):815-22. PubMed ID: 7937713
[TBL] [Abstract][Full Text] [Related]
4. Humanization of murine monoclonal antibodies through variable domain resurfacing.
Roguska MA; Pedersen JT; Keddy CA; Henry AH; Searle SJ; Lambert JM; Goldmacher VS; Blättler WA; Rees AR; Guild BC
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):969-73. PubMed ID: 8302875
[TBL] [Abstract][Full Text] [Related]
5. Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity.
Mateo C; Moreno E; Amour K; Lombardero J; Harris W; Pérez R
Immunotechnology; 1997 Mar; 3(1):71-81. PubMed ID: 9154469
[TBL] [Abstract][Full Text] [Related]
6. Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.
Khantasup K; Chantima W; Sangma C; Poomputsa K; Dharakul T
Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):404-17. PubMed ID: 26683180
[TBL] [Abstract][Full Text] [Related]
7. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
[TBL] [Abstract][Full Text] [Related]
8. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
[TBL] [Abstract][Full Text] [Related]
9. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor.
Papanastasiou D; Mamalaki A; Eliopoulos E; Poulas K; Liolitsas C; Tzartos SJ
J Neuroimmunol; 1999 Feb; 94(1-2):182-95. PubMed ID: 10376952
[TBL] [Abstract][Full Text] [Related]
11. Vl-linker-Vh orientation-dependent expression of single chain Fv-containing an engineered disulfide-stabilized bond in the framework regions.
Luo D; Mah N; Krantz M; Wilde K; Wishart D; Zhang Y; Jacobs F; Martin L
J Biochem; 1995 Oct; 118(4):825-31. PubMed ID: 8576099
[TBL] [Abstract][Full Text] [Related]
12. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
13. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.
Werther WA; Gonzalez TN; O'Connor SJ; McCabe S; Chan B; Hotaling T; Champe M; Fox JA; Jardieu PM; Berman PW; Presta LG
J Immunol; 1996 Dec; 157(11):4986-95. PubMed ID: 8943405
[TBL] [Abstract][Full Text] [Related]
14. A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing.
Roguska MA; Pedersen JT; Henry AH; Searle SM; Roja CM; Avery B; Hoffee M; Cook S; Lambert JM; Blättler WA; Rees AR; Guild BC
Protein Eng; 1996 Oct; 9(10):895-904. PubMed ID: 8931129
[TBL] [Abstract][Full Text] [Related]
15. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
16. Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation.
Kettleborough CA; Saldanha J; Heath VJ; Morrison CJ; Bendig MM
Protein Eng; 1991 Oct; 4(7):773-83. PubMed ID: 1798701
[TBL] [Abstract][Full Text] [Related]
17. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
Yang X; Hu W; Li F; Xia H; Zhang Z
Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
[TBL] [Abstract][Full Text] [Related]
18. Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs.
Pavlinkova G; Colcher D; Booth BJ; Goel A; Wittel UA; Batra SK
Int J Cancer; 2001 Dec; 94(5):717-26. PubMed ID: 11745468
[TBL] [Abstract][Full Text] [Related]
19. Improvement of anti-Burkholderia mouse monoclonal antibody from various phage-displayed single-chain antibody libraries.
Kim HS; Lo SC; Wear DJ; Stojadinovic A; Weina PJ; Izadjoo MJ
J Immunol Methods; 2011 Sep; 372(1-2):146-61. PubMed ID: 21787781
[TBL] [Abstract][Full Text] [Related]
20. Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library.
Son JH; Lee UH; Lee JJ; Kwon B; Kwon BS; Park JW
J Immunol Methods; 2004 Mar; 286(1-2):187-201. PubMed ID: 15087232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
